Edwards Lifesciences Valuation Overview

EW -- USA Stock  

USD 149.81  0.61  0.41%

Edwards Lifesciences shows prevailing Real Value of $133.50549999999998 per share. The current price of the firm is $149.81. At this time the firm appears to be over valued. Macroaxis computes value of Edwards Lifesciences from reviewing the firm fundamentals such as Shares Outstanding of 210.78M, Profit Margin of 16.25% and Current Valuation of 30.54B as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we advise to go long with undervalued instruments and to sell out overvalued instruments since at some point assets prices and their ongoing real values will submerge.
Valuation Drivers Correlation
Click cells to compare fundamentals   View All Correlations
Edwards Lifesciences Corporation Valuation Data Drivers
Net Income Per Employee    Enterprise Value    Market Capitalization    
Edwards Lifesciences Market Cap
Edwards Lifesciences Corporation is rated below average in market capitalization category among related companies. Market capitalization of Healthcare Products industry is currently estimated at about 172.76 Billion. Edwards Lifesciences retains roughly 31.22 Billion in market capitalization claiming about 18% of equities under Healthcare Products industry.
Capitalization  Revenue  Valuation  Workforce  Total debt
 Time Horizon     30 Days    Login   to change
Edwards Lifesciences Corporation is rated below average in price to book category among related companies. It is rated below average in price to sales category among related companies fabricating about  0.94  of Price to Sales per Price to Book. The ratio of Price to Book to Price to Sales for Edwards Lifesciences Corporation is roughly  1.06 

Current Market Valuation

Edwards Lifesciences Valuation Boundaries
Over Valued
July 19, 2018
149.81
Market Value
Downside
129.79
133.51
Real Value
Target Odds
  
164.79
Upside
Edwards Lifesciences is not too risky asset. Calculation of real value of Edwards Lifesciences is based on 1 month time horizon. Increasing Edwards Lifesciences time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Additionally see Investing Opportunities. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.